Heads up: UK PM Johnson to make statement on 22 February on plan to exit lockdown

12/02/2021 | 07:22 GMT

Bloomberg with the headline

One to mark on the calendar for the month. This comes as the UK virus situation is starting to get better and we are seeing the vaccine rollout progress smoothly.

ADVERTISEMENT - CONTINUE READING BELOW

Best in 2026

Sponsored

General Risk Warning

Best Prop Firm in 2026: Detailed Comparison

Best Futures Brokers in USA for 2026: Detailed Comparison

Best Prediction Market Platforms in 2026: Detailed Comparison

Best Forex Brokers in 2026: Detailed Comparison

Best Online Brokers in 2026: Detailed Comparison

ADVERTISEMENT - CONTINUE READING BELOW

Telegram Community

Gain Access

TT beats Q1 revenue/EPS, backlog up 46.6%. Raised FY EPS guidance, but margins dip.

StockStory

12m ago

REGN's 19% revenue growth & 15% adjusted EPS growth at 16.5 P/E is a buy signal despite Eylea's dip.

Motley Fool

19m ago

AMGN beats Q1 estimates with 5.8% revenue growth & 8% EPS beat. New drugs drive gains, but legacy products face headwinds.

StockStory

22m ago

AXSM jumps 22.9% on Alzheimer's drug approval; analysts raise price targets to $255.

Motley Fool

29m ago

PWR beats revenue/EPS estimates, lifts guidance. Strong backlog growth signals robust demand.

StockStory

36m ago

Heathrow's £49B runway faces airline pushback over costs; China fund eyes exit amid risk.

Telegraph

43m ago

ZTS's 9.1% revenue growth & 16.2x P/E show promise; IBM & CSGP face headwinds with soft growth & high P/E.

StockStory

47m ago

Telegram Community

Gain Access

Must Read

!"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|} !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}